95
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

Between a rock and a hard place: management of systemic lupus erythematosus and porphyria cutanea tarda

, , &
Pages 2689-2691 | Received 04 Mar 2022, Accepted 21 Mar 2022, Published online: 06 Apr 2022

References

  • Bolognia JL, Jorizzo JL, Rapini RP. Dermatology: 2-volume set. St. Louis (MO): Mosby; 2012.
  • Fritsch S, Wojcik AS, Schade L, et al. Increased photosensitivity? Case report of porphyria cutanea tarda associated with systemic lupus erythematosus. Rev Bras Reumatol. 2012;52(6):968–970.
  • Gibson GE, McEvoy MT. Coexistence of lupus erythematosus and porphyria cutanea tarda in fifteen patients. J Am Acad Dermatol. 1998;38(4):569–573.
  • Kalia S, Dutz JP. New concepts in antimalarial use and mode of action in dermatology. Dermatol Ther. 2007;20(4):160–174.
  • Sunkara B, Roofeh D, Silver S, et al. The devil’s in the dosing: severe drug-induced liver injury in a hydroxychloroquine-naive patient with subacute cutaneous lupus erythematosus and porphyria cutanea tarda. Lupus. 2018;27(8):1383–1386.
  • Kiedrowicz M, Kacalak-Rzepka A, Bielecka-Grzela S, et al. Antimalarial drugs in contemporary dermatologic therapy. Ann Acad Med Stetinensis. 2011;57(1):38.
  • Malkinson FD, Levitt L. Hydroxychloroquine treatment of porphyria cutanea tarda. Arch Dermatol. 1980;116(10):1147–1150.
  • Petersen CS, Thomsen K. High-dose hydroxychloroquine treatment of porphyria cutane tarda. J Am Acad Dermatol. 1992;26(4):614–619.
  • Harber LC, Bickers DR. Porphyria and pseudoporphyria. J Invest Dermatol. 1984;82(3):207–209.
  • Wolverton SE. Comprehensive dermatologic drug therapy: expert consult-online and print. Amsterdam, Netherlands: Elsevier Health Sciences; 2012.
  • Vickers CFH. Subacute systemic lupus erythematosus: porphyria. Br J Dermatol. 1962;74:155–156.
  • Harris MY, Mills GC, Levin WC. Coexistent systemic lupus erythematosus and porphyria. Arch Intern Med. 1966;117(3):425–428.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.